Back to Search Start Over

The cystathionine β-synthase/hydrogen sulfide pathway contributes to microglia-mediated neuroinflammation following cerebral ischemia.

Authors :
Zhang, Minjie
Wu, Xiaowei
Xu, Yingxiu
He, Meijun
Yang, Jiaying
Li, Jie
Li, Yuyao
Ao, Guizhen
Cheng, Jian
Jia, Jia
Source :
Brain, Behavior & Immunity. Nov2017, Vol. 66, p332-346. 15p.
Publication Year :
2017

Abstract

The mechanisms underlying neuroinflammation following cerebral ischemia remain unclear. Hydrogen sulfide (H 2 S), a newly identified gasotransmitter, has been reported to regulate inflammation. In the current study, we investigated whether the endogenous H 2 S production pathway contributed to microglia-mediated neuroinflammation following stroke. We used a mouse middle cerebral artery occlusion (MCAO) model and an in vitro cellular model to mimic ischemia-induced microglial neuroinflammation. Expression of the H 2 S synthase cystathionine β-synthase (CBS) and H 2 S synthetic activity were rapidly decreased in the ischemic brain tissue following MCAO. Consistently, when cultured microglia were polarized toward a pro-inflammatory phenotype with conditioned medium collected from neurons that had been subjected to oxygen-glucose deprivation (OGD neuron CM), they displayed reduced CBS expression and H 2 S production. Enhancing H 2 S bioavailability either by overexpressing CBS or by supplementing with exogenous H 2 S donors promoted a shift in microglial polarization from ischemia-induced pro-inflammatory phenotypes toward anti-inflammatory phenotypes. Mechanistically, microglia that were exposed to OGD neuron CM displayed reduced activation of AMP-activated protein kinase (AMPK), which was rescued by overexpressing CBS or by supplementing with H 2 S donors. Moreover, the promoting effects of H 2 S donors on microglial anti-inflammatory polarization were abolished by an AMPK inhibitor or CaMKKβ inhibitor. Our results suggested that reduced CBS-H 2 S-AMPK cascade activity contributed to microglia-mediated neuroinflammation following stroke. Targeting the CBS-H 2 S pathway is a promising therapeutic approach for ischemic stroke. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
08891591
Volume :
66
Database :
Academic Search Index
Journal :
Brain, Behavior & Immunity
Publication Type :
Academic Journal
Accession number :
125782262
Full Text :
https://doi.org/10.1016/j.bbi.2017.07.156